Human induced pluripotent stem cells (iPSCs) are a valuable source of differentiated cells for clinical cell therapy applications. As part of GMP safety requirements, scientists must ensure that their final differentiated cell product does not contain undifferentiated iPSCs. To achieve highly pure cell samples, scientists need cell sorting devices that are themselves GMP compliant.
Download this application note from Sony to learn how a GMP ready, closed cell sorting system streamlines cell therapy manufacturing workflows.
